Renu Bhatia
Vermogen: 37 400 $ op 31-05-2026
Vermogen: 37 400 $ op 31-05-2026
Renu Bhatia currently holds the position of Lead Independent Non-executive Director at HUTCHMED (China) Ltd. starting in 2026.
Dr. Bhatia is also a Director at Opharmic Technology (HK) Ltd. Education history includes graduate studies at The University of Hong Kong, a doctorate from the University of London, and an MBA from Yale University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-03-2026 | 16.000 ( 0% ) | 37 400 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| HUTCHMED (CHINA) LIMITED | Directeur/Bestuurslid | 13-05-2024 |
Opharmic Technology (HK) Ltd.
Opharmic Technology (HK) Ltd. Pharmaceuticals: MajorHealth Technology Develops ultrasonic ocular drug delivery platform | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
HUTCHMED (China) Ltd.
HUTCHMED (China) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products | Health Technology |
University of Hong Kong
University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opharmic Technology (HK) Ltd.
Opharmic Technology (HK) Ltd. Pharmaceuticals: MajorHealth Technology Develops ultrasonic ocular drug delivery platform | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau